Ledger.Open graph →
SEC Form D · filed February 22, 2022

Psammiad Therapeutics, Inc

Offering
$3.0M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DENVER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Matthew Veatch · Denver, COExecAnthony Gerber · Denver, COExec · DirectorMichael Eber · Denver, COExecMatthew Veatch · Denver, COExecAnthony Gerber · Denver, COExec · DirectorMichael Eber · Denver, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗